| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sophie E Legge, Antonio F Pardiñas, Marinka Helthuis, John A Jansen, Karel Jollie, Steven Knapper, James H MacCabe, Dan Rujescu, David A Collier, Michael C O'Donovan, Michael J Owen, James T R Walter. A genome-wide association study in individuals of African ancestry reveals the importance of the Duffy-null genotype in the assessment of clozapine-related neutropenia. Molecular psychiatry. vol 24. issue 3. 2019-12-02. PMID:30647433. |
we sought to identify risk alleles in the first genome-wide association study of neutrophil levels during clozapine treatment, in 552 individuals with treatment-resistant schizophrenia and robustly inferred african genetic ancestry. |
2019-12-02 |
2023-08-13 |
Not clear |
| Morten Brix Schou, Ole Kristian Drange, Sverre Georg Sæthe. Differences between counties in the prescribing of clozapine. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. vol 139. issue 13. 2019-12-02. PMID:31556524. |
norwegian national guidelines recommend that clozapine be offered to patients with schizophrenia after two failed attempts with other antipsychotic drugs. |
2019-12-02 |
2023-08-13 |
Not clear |
| Ulrich Schall, Stanley V. Catts, Shail Chaturvedi, Barbara Liebert, Joanna Redenbach, Frini Karayanidis, Philip B. War. The effect of clozapine therapy on frontal lobe dysfunction in schizophrenia: neuropsychology and event-related potential measures. The international journal of neuropsychopharmacology. vol 1. issue 1. 2019-11-20. PMID:11281941. |
the effect of clozapine therapy on frontal lobe dysfunction in schizophrenia: neuropsychology and event-related potential measures. |
2019-11-20 |
2023-08-12 |
Not clear |
| Ulrich Schall, Stanley V. Catts, Shail Chaturvedi, Barbara Liebert, Joanna Redenbach, Frini Karayanidis, Philip B. War. The effect of clozapine therapy on frontal lobe dysfunction in schizophrenia: neuropsychology and event-related potential measures. The international journal of neuropsychopharmacology. vol 1. issue 1. 2019-11-20. PMID:11281941. |
there are several reports that performance-based measures as well as symptom ratings improve with clozapine in patients with schizophrenia who previously responded poorly to typical neuroleptic treatment. |
2019-11-20 |
2023-08-12 |
Not clear |
| Ulrich Schall, Stanley V. Catts, Frini Karayanidis, Philip B. War. Auditory event-related potential indices of fronto-temporal information processing in schizophrenia syndromes: valid outcome prediction of clozapine therapy in a three-year follow-up. The international journal of neuropsychopharmacology. vol 2. issue 2. 2019-11-20. PMID:11281974. |
auditory event-related potential indices of fronto-temporal information processing in schizophrenia syndromes: valid outcome prediction of clozapine therapy in a three-year follow-up. |
2019-11-20 |
2023-08-12 |
human |
| Allan Z. Safferman, Rafael Munn. Combining Clozapine with ECT. Convulsive therapy. vol 8. issue 2. 2019-11-20. PMID:11941161. |
we describe the safe and effective use of the combination of clozapine and ect in a patient with schizophrenia who had lost responsiveness to clozapine alone. |
2019-11-20 |
2023-08-12 |
Not clear |
| Cristiana Silvestrini, Tiziana Arcangeli, Massimo Biondi, Paola Pancher. A second trial of clozapine in a case of granulocytopenia. Human psychopharmacology. vol 15. issue 4. 2019-11-20. PMID:12404322. |
we report on the case of a 29-year-old woman with dsm-iv undifferentiated schizophrenia who developed agranulocytosis after 5 years of 300 mg/day clozapine treatment. |
2019-11-20 |
2023-08-12 |
Not clear |
| Yaffa Vered, Baruch Spivak, Allon Nechmad, Nina Schlapnikov, Eran Graff, Israel Feinberg, Daniel Gruper, Mordechai Weiss, Moshe Kotler, Abraham Weizman, Roberto Meste. Plasma serotonin response to carbohydrate-rich food in chronic schizophrenic patients: clozapine versus classic antipsychotic agents. Human psychopharmacology. vol 16. issue 5. 2019-11-20. PMID:12404560. |
in the present study, we used the carbohydrate-rich meal test as an indicator of 5-ht activity in 12 patients with chronic schizophrenia maintained for at least 6 months on clozapine. |
2019-11-20 |
2023-08-12 |
human |
| Yaffa Vered, Baruch Spivak, Allon Nechmad, Nina Schlapnikov, Eran Graff, Israel Feinberg, Daniel Gruper, Mordechai Weiss, Moshe Kotler, Abraham Weizman, Roberto Meste. Plasma serotonin response to carbohydrate-rich food in chronic schizophrenic patients: clozapine versus classic antipsychotic agents. Human psychopharmacology. vol 16. issue 5. 2019-11-20. PMID:12404560. |
our results indicate that in patients with chronic schizophrenia 5-ht responsivity to the natural challenge of carbohydrate-rich meals is lower in those treated with clozapine than in those given classic antipsychotic agents. |
2019-11-20 |
2023-08-12 |
human |
| Mohammad Sharaf. Comparison of Classical and Clozapine Treatment on Schizophrenia Using Positive and Negative Syndrome Scale of Schizophrenia (PANSS) and SPECT Imaging. International journal of medical sciences. vol 2. issue 2. 2019-11-20. PMID:15968344. |
comparison of classical and clozapine treatment on schizophrenia using positive and negative syndrome scale of schizophrenia (panss) and spect imaging. |
2019-11-20 |
2023-08-12 |
Not clear |
| Pichai Ittasakul, Anthony Archer, Jennifer Kezman, Wanlop Atsariyasing, Morris B Goldma. Rapid Re-challenge with Clozapine Following Pronounced Myocarditis in a Treatment-Resistance Schizophrenia Patient. Clinical schizophrenia & related psychoses. 2019-11-20. PMID:24047759. |
rapid re-challenge with clozapine following pronounced myocarditis in a treatment-resistance schizophrenia patient. |
2019-11-20 |
2023-08-12 |
Not clear |
| Scott R Clark, Lisa Wilton, Bernhard T Baune, Nicholas Procter, Harry Husti. A state-wide quality improvement system utilising nurse-led clinics for clozapine management. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. vol 22. issue 3. 2019-11-20. PMID:24811715. |
this paper describes the implementation of a state-wide clozapine management system to improve the quality of care for those with treatment-resistant schizophrenia. |
2019-11-20 |
2023-08-13 |
Not clear |
| Tanya Ebert, Mila Schechtman, Yael Midbari, Abraham Weizman, Meir Shinitzky, Baruch Spiva. Effect of Clozapine and Other Antipsychotics on the Level of Platelet-Associated Autoantibodies in Children with Schizophrenia: A Longitudinal Follow-Up Study. Neuropsychobiology. vol 71. issue 2. 2019-11-20. PMID:25871884. |
effect of clozapine and other antipsychotics on the level of platelet-associated autoantibodies in children with schizophrenia: a longitudinal follow-up study. |
2019-11-20 |
2023-08-13 |
human |
| Mary F Brunette, Ree Dawson, Christopher D O'Keefe, Meera Narasimhan, Douglas L Noordsy, Joanne Wojcik, Alan I Gree. A randomized trial of clozapine vs. other antipsychotics for cannabis use disorder in patients with schizophrenia. Journal of dual diagnosis. vol 7. issue 1-2. 2019-11-20. PMID:25914610. |
a randomized trial of clozapine vs. other antipsychotics for cannabis use disorder in patients with schizophrenia. |
2019-11-20 |
2023-08-13 |
Not clear |
| Mary F Brunette, Ree Dawson, Christopher D O'Keefe, Meera Narasimhan, Douglas L Noordsy, Joanne Wojcik, Alan I Gree. A randomized trial of clozapine vs. other antipsychotics for cannabis use disorder in patients with schizophrenia. Journal of dual diagnosis. vol 7. issue 1-2. 2019-11-20. PMID:25914610. |
we launched a randomized controlled trial to assess the impact of clozapine compared with treatment as usual on cannabis use in patients with schizophrenia and co-occurring cannabis use disorder. |
2019-11-20 |
2023-08-13 |
Not clear |
| Leslie Citrome, Joseph P McEvoy, Stephen R Sakla. A Guide to the Management of Clozapine-Related Tolerability and Safety Concerns. Clinical schizophrenia & related psychoses. 2019-11-20. PMID:27454214. |
clozapine is a highly effective antipsychotic medication, which provides a range of significant benefits for patients with schizophrenia, and is the standard of care for treatment-resistant schizophrenia as well as for reducing the risk of suicidal behaviors in schizophrenia and schizoaffective disorder. |
2019-11-20 |
2023-08-13 |
Not clear |
| Rajkumar A P, Chitra C, Bhuvaneshwari S, Poonkuzhali B, Kuruvilla A, Jacob K . Clinical Predictors of Response to Clozapine in Patients with Treatment Resistant Schizophrenia. Psychopharmacology bulletin. vol 44. issue 3. 2019-11-20. PMID:27738362. |
clinical predictors of response to clozapine in patients with treatment resistant schizophrenia. |
2019-11-20 |
2023-08-13 |
Not clear |
| Rajkumar A P, Chitra C, Bhuvaneshwari S, Poonkuzhali B, Kuruvilla A, Jacob K . Clinical Predictors of Response to Clozapine in Patients with Treatment Resistant Schizophrenia. Psychopharmacology bulletin. vol 44. issue 3. 2019-11-20. PMID:27738362. |
despite clozapine's superior clinical efficacy in treatment resistant schizophrenia (trs), its adverse effects, need for periodic leukocyte monitoring, cost and variable clinical outcomes make the therapeutic decision making process difficult and mandate a clinical need to predict its treatment response. |
2019-11-20 |
2023-08-13 |
Not clear |
| Zoubir Djerada, Françoise Daviet, Pierre-Michel Llorca, Alain Eschalier, Franck Saint-Marcoux, Danièle Bentué-Ferrer, Fréderic Liber. [Therapeutic drug monitoring of clozapine]. Therapie. 2019-11-20. PMID:27771104. |
clozapine is a prototypical atypical antipsychotic used to treat severe schizophrenia and for which a therapeutic drug monitoring (tdm) is quite commonly proposed. |
2019-11-20 |
2023-08-13 |
Not clear |
| Richard Gray, Nicola Smedley, Kim Miller, Simon Vearnal. Research in Brief: Health education needs of people with schizophrenia taking clozapine. Journal of clinical nursing. vol 5. issue 5. 2019-11-20. PMID:28880493. |
research in brief: health education needs of people with schizophrenia taking clozapine. |
2019-11-20 |
2023-08-13 |
Not clear |